Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
9 studies found for:    19423869 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Safety and Efficacy of an H1N1 Influenza Vaccine in People With Asthma
Condition: H1N1 Influenza Virus
Interventions: Biological: H1N1 vaccine high dose;   Biological: H1N1 vaccine low dose
2 Completed
Has Results
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
Conditions: HIV Infections;   H1N1 Influenza Virus
Intervention: Biological: Influenza A (H1N1) monovalent vaccine
3 Completed
Has Results
Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth
Conditions: HIV Infections;   H1N1 Influenza Virus
Intervention: Biological: Influenza A (H1N1) 2009 monovalent vaccine
4 Completed Immunogenicity, Safety, and Tolerability of MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With HIV-1 Infection
Conditions: H1N1 Influenza Virus;   Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Interventions: Biological: Focetria®;   Biological: Begrivac®
5 Completed Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid Tumors
Conditions: H1N1 Influenza Virus;   Invasive Solid Tumors
Interventions: Biological: adjuvanted A(H1N1) influenza vaccine;   Biological: non-adjuvanted A(H1N1) influenza vaccine
6 Recruiting Testing the AVI-7100 Flu Drug in Healthy Volunteers
Condition: Influenza
Intervention: Drug: AVI-7100 versus placebo
7 Recruiting INSIGHT Respiratory Virus Outpatient Study (FLU 002 Plus)
Condition: Influenza and Other Novel Respiratory Viruses
Intervention:
8 Completed Immunogenicity, Safety, and Tolerability of an MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With Chronic Pulmonary Disease, Chronic Heart Disease, or Diabetes Mellitus
Conditions: H1N1 Influenza Virus;   Chronic Pulmonary Disease;   Chronic Heart Disease;   Diabetes Mellitus
Interventions: Biological: Focetria®;   Biological: Fluad®;   Biological: Begrivac®
9 Recruiting INSIGHT Respiratory Virus Hospitalization Study (FLU 003 Plus)
Conditions: Influenza;   Novel Respiratory Virus-1 MERS-CoV;   Novel Respiratory Virus-2 SARS-CoV
Intervention:

Indicates status has not been verified in more than two years